Eriko Aoyama

1.5k citations
48 papers · 1.2k indexed · h-index 22
Topics
Connective Tissue Growth Factor Research (35 papers)Osteoarthritis Treatment and Mechanisms (9 papers)Fibroblast Growth Factor Research (5 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Eriko Aoyama

46 papers receiving 1.2k citations

Peers

Eriko Aoyama
Comparison fields: 5 of 91
  • Molecular Biology 873
  • Rheumatology 224
  • Cancer Research 149
  • Oncology 133
  • Cell Biology 117
Replace Fumitaka Kugimiya with:
Fumitaka Kugimiya Japan
Harumi Kawaki Japan
Weike Si China
Hayk Hovhannisyan United States
Xiaolan Du China
Hiromitsu Yamamoto Japan
Takashi Izawa Japan
Kei Yamana Japan
Jennifer H. Jonason United States
Peihong Su China
Eriko Aoyama relative to Fumitaka Kugimiya Japan Fumitaka Kugimiya's profile →
Citations per field
00.5×1.5×2.4×
Fumitaka Kugimiya · 1×
Citations per year

Countries citing papers authored by Eriko Aoyama

Since Specialization
Citations

This map shows the geographic impact of Eriko Aoyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Aoyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Aoyama more than expected).

Fields of papers citing papers by Eriko Aoyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Aoyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Aoyama. The network helps show where Eriko Aoyama may publish in the future.

Co-authorship network of co-authors of Eriko Aoyama

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Aoyama. A scholar is included among the top collaborators of Eriko Aoyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Aoyama. Eriko Aoyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 14
2 23
3 28
4 53
5 3
6 20
7 26
8 54
9 31
10 55
11 5
12 39
13 43
14 39
15 51
16 65
17 78
18 11
19 20
20 1

About Eriko Aoyama

Eriko Aoyama is a scholar working on Molecular Biology, Rheumatology and Immunology and Allergy, having authored 48 papers that have together received 1.2k indexed citations. Recurring topics across this work include Connective Tissue Growth Factor Research (35 papers), Osteoarthritis Treatment and Mechanisms (9 papers) and Fibroblast Growth Factor Research (5 papers). The work is most often cited by research in Rheumatology (224 citations), Molecular Biology (873 citations) and Cancer Research (149 citations). Eriko Aoyama has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Masaharu Takigawa, Satoshi Kubota, Takashi Nishida, Takako Hattori, Takanori Eguchi, Karen M. Lyons, Takuo Kuboki, Takashi Yamashiro, Mitsuhiro Hoshijima and Seiji Kondo. Their work appears in journals such as The Journal of Cell Biology, PLoS ONE and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026